We are live on !
Find out more
Man Group Portfolio holdings
AUM
$62.7B
Turnover
25.36%
1-Year Est. Return
29.77%
This Fund
S&P 500
This Quarter Est. Return
+17.8%
1 Year Est. Return
+29.77%
3 Year Est. Return
+99.46%
5 Year Est. Return
+125.78%
10 Year Est. Return
–
AUM
$62.7B
AUM Growth
+$7.58B
(+14%)
Cap. Flow
+$636M
Cap. Flow % of AUM
Cap. Flow %
1.01%
Top 10 Holdings %
Top 10 Hldgs %
16.65%
Holding
2,689
New
309
Increased
875
Reduced
1,007
Closed
373
Avg Time Held
Equity + Options
1.3
years
Top 10 Avg Time Held
Equity + Options
1.4
years
Top 20 Avg Time Held
Equity + Options
1.1
years
Avg Time Held Equity only
1.3
years
Top 10 Avg Time Held Equity only
1.4
years
Top 20 Avg Time Held Equity only
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$831M |
| 2 |
LyondellBasell Industries
LYB
|
+$221M |
| 3 |
L3Harris
LHX
|
+$176M |
| 4 |
Apple
AAPL
|
+$176M |
| 5 |
NVIDIA
NVDA
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$259M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$210M |
| 3 |
HDFC Bank
HDB
|
+$195M |
| 4 |
Ford
F
|
+$174M |
| 5 |
Silicon Motion
SIMO
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.78% |
| 2 | Miscellaneous | 17.39% |
| 3 | Financials | 9.96% |
| 4 | Healthcare | 9.22% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1626
Vontier
VNT
$4.65B
| $1.48M | ﹤0.01% |
51,099
-30,955
| -38% | -$989K |
2023 Q4
10 quarters
|
|
1627
Cytokinetics
CYTK
$8.51B
| $1.48M | ﹤0.01% |
17,393
+6,930
| +66% | +$498K |
2025 Q4
2 quarters
|
|
1628
Financial Institutions
FISI
$800M
| $1.46M | ﹤0.01% |
37,570
+7,629
| +25% | +$271K |
2026 Q1
1 quarter
|
|
1629
Aquestive Therapeutics
AQST
$502M
| $1.46M | ﹤0.01% |
+351,700
| New | +$1.48M |
2026 Q2
0 quarters
|
|
1630
Allogene Therapeutics
ALLO
$432M
| $1.46M | ﹤0.01% |
701,901
+547,218
| +354% | +$1.2M |
2025 Q1
5 quarters
|
|
1631
N-able
NABL
$967M
| $1.46M | ﹤0.01% |
397,145
+159,476
| +67% | +$663K |
2025 Q4
2 quarters
|
|
1632
Flowco Holdings
FLOC
$863M
| $1.46M | ﹤0.01% |
68,278
-9,964
| -13% | -$238K |
2025 Q2
4 quarters
|
|
1633
Affirm
AFRM
$23.6B
| $1.45M | ﹤0.01% |
17,834
-4,760
| -21% | -$311K |
2023 Q4
10 quarters
|
|
1634
Fluence Energy
FLNC
$800M
| $1.45M | ﹤0.01% |
73,042
-86,901
| -54% | -$1.62M |
2026 Q1
1 quarter
|
|
1635
Navan Inc
NAVN
$7.02B
| $1.45M | ﹤0.01% |
+63,413
| New | +$1.16M |
2026 Q2
0 quarters
|
|
1636
Sotera Health
SHC
$5.17B
| $1.44M | ﹤0.01% |
81,321
-68,680
| -46% | -$1.08M |
2025 Q4
2 quarters
|
|
1637
Wynn Resorts
WYNN
$7.49B
| $1.44M | ﹤0.01% |
14,862
+7,585
| +104% | +$782K |
2023 Q4
10 quarters
|
|
1638
Metropolitan Bank Holding Corp
MCB
$1.2B
| $1.44M | ﹤0.01% |
14,601
+12,135
| +492% | +$1.1M |
2026 Q1
1 quarter
|
|
1639
AMC Entertainment Holdings
AMC
$2.59B
| $1.44M | ﹤0.01% |
757,528
-136,917
| -15% | -$236K |
2026 Q1
1 quarter
|
|
1640
OP Bancorp
OPBK
$220M
| $1.44M | ﹤0.01% |
96,016
+10,088
| +12% | +$144K |
2025 Q2
4 quarters
|
|
1641
Evertec
EVTC
$1.94B
| $1.44M | ﹤0.01% |
51,751
+41,931
| +427% | +$1.11M |
2026 Q1
1 quarter
|
|
1642
Preformed Line Products
PLPC
$1.61B
| $1.44M | ﹤0.01% |
3,497
-14,478
| -81% | -$5.07M |
2025 Q3
3 quarters
|
|
1643
Adtran
ADTN
$524M
| $1.43M | ﹤0.01% |
102,762
+48,591
| +90% | +$758K |
2024 Q4
6 quarters
|
|
1644
Liberty Latin America Class C
LILAK
$1.57B
| $1.43M | ﹤0.01% |
183,344
-233,265
| -56% | -$1.69M |
2026 Q1
1 quarter
|
|
1645
Korn Ferry
KFY
$4.38B
| $1.43M | ﹤0.01% |
21,439
+150
| +0.7% | +$10.1K |
2023 Q4
10 quarters
|
|
1646
IonQ
IONQ
$12.7B
| $1.43M | ﹤0.01% |
26,798
-158,559
| -86% | -$8.04M |
2024 Q4
6 quarters
|
|
1647
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.4B
| $1.43M | ﹤0.01% |
+17,264
| New | +$1.43M |
2026 Q2
0 quarters
|
|
1648
Procore
PCOR
$9.6B
| $1.43M | ﹤0.01% |
35,114
+25,702
| +273% | +$1.27M |
2025 Q3
3 quarters
|
|
1649
Aurinia Pharmaceuticals
AUPH
$2.24B
| $1.42M | ﹤0.01% |
83,888
-867,524
| -91% | -$13.9M |
2025 Q2
4 quarters
|
|
1650
BlueLinx
BXC
$603M
| $1.42M | ﹤0.01% |
+23,003
| New | +$1.24M |
2026 Q2
0 quarters
|
|
Similar funds
Man Group's Q2 2026 Portfolio in Review
As of Q2 2026, Man Group held 2,689 positions worth $62.7B, up 14% from $55.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Man Group's Q2 2026 filing shows 309 new, 875 increased, 1,007 reduced and 373 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,146,541 shares worth $856M. The largest sale was Microsoft, an estimated $259M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Financials.
- Man Group's largest Q2 2026 buy was State Street SPDR S&P 500 ETF Trust: 1,146,541 shares worth $856M.
- Man Group added most to LyondellBasell Industries in Q2 2026, an estimated $221M increase.
- Man Group's biggest Q2 2026 reduction was Microsoft, cutting an estimated $259M.
- Man Group fully exited Clearwater Analytics in Q2 2026, selling an estimated $84.6M.
- Man Group's ten largest holdings make up 17% of its $62.7B portfolio in Q2 2026.
- Man Group opened 309 new positions and closed 373 in Q2 2026.
- Man Group's portfolio value rose 14% quarter-over-quarter to $62.7B.
Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.